Learning Objectives:

  1. Briefly discuss pathophysiology and stages of thrombus formation
  2. Describe risk of DVT/PE in both CKD and ESRD population
  3. Outline current data for anticoagulation in the CKD/ESRD population, focusing on atrial fibrillation treatment
  4. Briefly discuss heparin in CKD/ESRD population
  5. Touch on current information regarding anticoagulation in renal transplant patients
Session date: 
Thursday, October 1, 2020 - 4:00pm to 5:00pm
Location: 
Zoom meeting
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Abhishek Pulla, MD